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Phosphorylation-induced conformation of β2-
adrenoceptor related to arrestin recruitment
revealed by NMR
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Takumi Ueda 1,3, Hideo Iwaï 4 & Ichio Shimada1
The C-terminal region of G-protein-coupled receptors (GPCRs), stimulated by agonist
binding, is phosphorylated by GPCR kinases, and the phosphorylated GPCRs bind to arrestin,
leading to the cellular responses. To understand the mechanism underlying the formation of
the phosphorylated GPCR-arrestin complex, we performed NMR analyses of the phos-
phorylated β2-adrenoceptor (β2AR) and the phosphorylated β2AR–β-arrestin 1 complex, in the
lipid bilayers of nanodisc. Here we show that the phosphorylated C-terminal region adheres
to either the intracellular side of the transmembrane region or lipids, and that the phos-
phorylation of the C-terminal region allosterically alters the conformation around M2155.54
and M2796.41, located on transemembrane helices 5 and 6, respectively. In addition, we
found that the conformation induced by the phosphorylation is similar to that corresponding
to the β-arrestin-bound state. The phosphorylation-induced structures revealed in this study
propose a conserved structural motif of GPCRs that enables β-arrestin to recognize dozens of
GPCRs.
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G-protein-coupled receptors (GPCRs), which constitute thelargest family of cell surface receptors in the humangenome, are receptors for various hormones and neuro-
transmitters, and >30% of current drugs target GPCRs. Agonist
binding to GPCRs leads to the activation of signal transduction,
mediated by heterotrimeric G-proteins. The C-terminal region of
activated GPCRs is phosphorylated by GPCR kinases (GRKs),
and the phosphorylated GPCRs bind to arrestins. Arrestins
bound to activated and phosphorylated GPCRs regulate the
duration and strength of the cellular responses, by steric preclu-
sion of the coupling between GPCRs and G-proteins, promotion
of the GPCR internalization via clathrin-coated pits, and G-
protein-independent, arrestin-mediated signal transductions.
Activation of arrestins by GPCRs is required for cell home-
ostasis1, and information about the arrestin activation mechanism
will facilitate the development of drugs that selectively activate
either the G-protein- or arrestin-mediated signal transductions,
leading to reduced side effects. The phosphorylation of the C-
terminal region of GPCRs by GRKs, as well as the agonist binding
to GPCRs, is a critical step for the formation and activation of the
GPCR–arrestin complex.
The tertiary structures of arrestins have been solved by X-ray
crystallography2–5. In addition, the crystal structures of a complex
between arrestin and a phosphorylated peptide that mimics the
C-terminal region of a GPCR6 and the arrestin 1 bound to
rhodopsin7, 8 have been solved. These structures indicated that
the ﬁnger loop and N-domain of arrestin bind to the cytoplasmic
cavity and the phosphorylated C-terminal region of GPCRs,
respectively. However, structural information about the phos-
phorylated GPCRs is not available, although the structures of
unphosphorylated GPCRs have been solved in various forms9–11.
To understand the mechanism enabling the interactions of
GPCRs with arrestin, the structures of the phosphorylated GPCRs
must be clariﬁed.
A lipid bilayer environment is reportedly preferable for GPCR
phosphorylation by GRK12. It was recently reported that recon-
stituted high density lipoproteins (rHDLs), which are also known
as nanodiscs13, can accommodate membrane proteins within a
10-nm-diameter disc-shaped lipid bilayer14. Our NMR studies
revealed that the conformational equilibria of β2-adrenoceptor
(β2AR), one of the prototypical class A GPCRs, as well as those of
other membrane proteins, more accurately reﬂect the physiolo-
gical events when embedded in the lipid bilayer of rHDLs, as
compared to in detergent micelles15–17.
Here, we show the conformation of the transmembrane (TM)
region and the C-terminal region of phosphorylated β2AR
embedded in the lipid bilayers of rHDLs by using NMR, together
with the amino acid-selective and segment-selective isotope
labeling methods16, 18 (Fig. 1). This study identiﬁed a
phosphorylation-induced conformation of β2AR. On the basis of
the conformation of the phosphorylated β2AR, we will discuss the
mechanism by which the activated and phosphorylated GPCRs
are able to recognize β-arrestins.
Results
Preparation of the C-terminal segmentally-labeled β2AR. The
C-terminal region of β2AR possesses seven serine residues and
four threonine residues, which are reportedly phosphorylated by
GRKs (Fig. 1). For the observation of the NMR resonances from
the β2AR C-terminal region, the C-terminal region of β2AR was
segmentally labeled. The non-labeled TM region of β2AR (1–348),
expressed in an insect cell expression system, was fused with the
labeled C-terminal region (349–413), expressed in an E. coli
expression system, using intein-mediated protein trans-splicing
(PTS)19, 20 (Fig. 2a). Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS–PAGE) analyses revealed that the PTS
reaction proceeded with ~80% efﬁciency (Supplementary Fig. 1a).
The segmentally labeled β2ARs were reconstituted into the lipid
bilayers of rHDLs. The size exclusion chromatography analysis
revealed that the puriﬁed β2ARs in rHDLs are monodisperse, with
a Stokes diameter of 11 nm, in good agreement with the pre-
viously reported rHDL size13 (Supplementary Fig. 1b).
For the evaluation of the β-arrestin signaling, the phosphor-
ylation of β2AR in rHDLs by GRK2, which is the main GPCR
kinase of β2AR, was analyzed, according to the previous report
that the relative activity of the ligand to induce the phosphoryla-
tion of a GPCR correlates well with the efﬁcacy of the β-arrestin
signaling21. SDS-PAGE analyses of rHDL-embedded β2AR
phosphorylated by GRK2 using Pro-Q® Diamond staining, which
stains phosphorylated proteins, revealed that, in the presence of
the full agonist, the amount of phosphorylated β2AR was
remarkably larger than that in the presence of the inverse
agonist, carazolol (Supplementary Fig. 1c, Supplementary Fig. 9).
Therefore, the obtained β2AR retains the activity to stimulate
arrestin-mediated signaling in a ligand-dependent manner.
Conformation of the phosphorylated C-terminal region. In the
1H-15N heteronuclear single-quantum coherence (HSQC) spectra
of β2AR, in which the 63 residues in the C-terminal region were
segmentally labeled with 2H, 13C, and 15N, with or without the
phosphorylation by GRK2, signals apparently originating from
the 63 residues in the C-terminal region were observed (Fig. 2b
and Supplementary Fig. 2b). Hereafter, β2AR, in which
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Fig. 1 Distribution of the NMR probes on the structure of β2AR. The crystal
structure of β2AR (PDB ID: 3SN6) is shown as a ribbon model. The N-
terminal region, intracellular loop 3, and the C-terminal region, which are
either substituted with T4 lysozyme, not observed, or truncated, are shown
with dotted lines. The methionine residues observed for the analysis of the
conformation of the TM region are shown as sticks. M822.53, M2155.54, and
M2796.41, with resonances that reportedly exhibit remarkable chemical
shift change upon activation, are shown as red sticks. The C-terminal
region, which was segmentally labeled for the NMR observation, is shown
by a red dotted line. The putative phosphorylated residues in the C-terminal
region are shown. The structural model was prepared with Cuemol (http://
www.cuemol.org/)
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C-terminal region was labeled with 2H, 13C, and 15N, is referred
to as {Cterm-[2H,13C,15N]} β2AR. The resonance assignments of
the spectra with or without the phosphorylation were accom-
plished by standard triple resonance experiments for {Cterm-
[2H,13C,15N]} β2AR-rHDL and comparisons with the spectra of
the peptide corresponding to the C-terminal region of β2AR
(Supplementary Fig. 2b). On the basis of comparisons between
the spectra of the unphosphorylated β2AR and those of the
phosphorylated β2AR, the degrees of the GRK2-mediated phos-
phorylation of each serine and threonine residue in the C-
terminal region were calculated (Supplementary Table 1 and
Supplementary Note 1).
In the unphosphorylated state, all resonances derived from the
C-terminal region of β2AR were sharp and exhibited small amide
proton chemical shift dispersion, and the 13Cα chemical shift
differences from those of a random coil were <1.6 ppm
(Supplementary Fig. 3). Therefore, in the unphosphorylated
state, the C-terminal region of β2AR is highly ﬂexible and does
not form a speciﬁc secondary structure22. In the phosphorylated
state, the amide resonances derived from G361–L413 were sharp
and the 13Cα chemical shift differences from those of a random
coil were <1.6 ppm (Fig. 2b and Supplementary Fig. 3),
suggesting that these residues are also ﬂexible even in the
phosphorylated state. In contrast, the amide resonances derived
from G353–T360 could not be observed (Fig. 2b). Hereafter, the
G353–T360 region is referred to as the “TM-proximal region” and
the rest of the C-terminal region, G361–L413, is referred to as the
“TM-distal region”.
Resonances from methyl groups can be observed with higher
sensitivity than those from amide groups, and the TM-proximal
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Fig. 2 NMR spectra of the C-terminal region of the segmentally labeled β2AR. a Schematic diagram of the preparation of segmentally labeled β2AR. b
Overlay of the 1H-15N HSQC spectra of the unphosphorylated (black) and phosphorylated (red) {Cterm- [2H, 13C, 15N]} β2AR in rHDLs. Resonances that
were not observed in the phosphorylated β2AR are indicated with boxes, and resonances that exhibited different chemical shifts between the
unphosphorylated and phosphorylated spectra are indicated with arrows. c Overlay of the 1H-13C HMQC spectra of {Cterm- [2H, Thrγ2-, Ileδ1-[13C,1H]}
β2AR in rHDLs. d 1H and 13C linewidths of the T360 methyl signals of the unphosphorylated (gray bars) and phosphorylated (red bars) β2AR in rHDL. The
linewidths were calculated by ﬁtting the Lorentzian function to the signals using Topspin 3.1. The error bars indicate the standard errors of the ﬁt
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region contains a single methyl group at T360. Therefore, we
utilized the T360γ2 methyl group to investigate the conformation
of the TM-proximal region of the phosphorylated β2AR. To
overcome the signal overlaps, we mutated the threonine residues
in the TM-distal region, and utilized a methyl group of I399 to
probe the conformation of the TM-distal region. In the 1H-13C
HMQC spectra of the {Cterm- [2H, Thrγ2/Ileδ1-13C1H3]} β2AR
mutant, resonances corresponding to T360γ2 and I399δ1 were
observed (Fig. 2c). In the phosphorylated state, the chemical shift
of the I399δ1 methyl resonance was almost identical to that in the
unphosphorylated state. Interestingly, the T360γ2 methyl reso-
nance in the phosphorylated state exhibited remarkable 13C line
broadening (Fig. 2d). The 13C chemical shifts of the threonine
methyl signals are reportedly dependent on the sidechain χ1
angles23. Therefore, the TM-proximal region of the C-terminal
region of phosphorylated β2AR is not fully disordered, and
undergoes exchange among multiple conformations that adopt
different χ1 angles of T360, on the order of microseconds to
milliseconds.
Conformation of the TM helices of phosphorylated β2AR. To
investigate the conformation of the TM region of phosphorylated
β2AR, we observed the NMR resonances from the methionine
methyl groups in this region of β2AR in the phosphorylated state.
We prepared the phosphorylated [2H-9AA, αβγ-2H-, methyl-13C-
Met] β2AR 4Met mutant, in which four solvent- or lipid-exposed
methionine residues were mutated, as previously described16,
embedded in rHDLs. β2AR/4Met possesses ﬁve methionine resi-
dues: M361.35, M401.39, M822.53, M2155.54, and M2796.41
(superscripts indicate Ballesteros–Weinstein numbering24)
(Fig. 1). M822.53, M2155.54, and M2796.41 assume distinctly dif-
ferent conformations between the crystal structures of β2AR
bound to an inverse agonist and β2AR bound to a full agonist and
a G protein, and the resonances from these residues of the β2AR/
4Met mutant exhibited large differences between each ligand-
bound state16, 18.
In the 1H-13C HMQC spectra of the [2H-9AA, αβγ-2H-,
methyl-13C-Met] β2AR in rHDLs in the full agonist-bound state,
the resonances from M361.35, M401.39, and M822.53 showed the
same chemical shifts between the phosphorylated state and the
unphosphorylated state. Interestingly, the 1H and 13C chemical
shifts of the resonance from M2155.54 were remarkably different
from those of the unphosphorylated β2AR. Furthermore, the
resonance from M2796.41 was not observed, suggesting that this
signal was broadened due to the exchange between the multiple
conformations in the phosphorylated state (Fig. 3).
Adhesion of the C-terminal region to the membrane surface.
For further investigation of the conformation of the phosphory-
lated β2AR, the interaction between the C-terminal region and the
membrane surface, which is composed of the intracellular side of
the TM region of β2AR and lipids, was examined by cross-
saturation experiments25. As the amide resonances derived from
the TM-proximal region could not be observed in the phos-
phorylated state, methyl resonances were utilized in the cross-
saturation experiments. β2AR in rHDLs, in which the C-terminal
region of β2AR and MSP1 are perdeuterated and the methyl
groups of T360γ2 and I399δ1 of β2AR are labeled with 13C, was
irradiated with a frequency corresponding to the aromatic proton
resonances, exclusively affecting β2AR except for its C-terminal
region, because no aromatic protons exist in the C-terminal
region (Fig. 4a). The saturation in the aromatic protons of β2AR
is instantaneously transferred to all of the hydrogen atoms of the
TM region of β2AR and the lipids in rHDLs, which have high
proton density, in a phenomenon known as the spin diffusion
effect. Although the C-terminal region of β2AR is not directly
affected by the radiofrequency ﬁeld, the saturation can be trans-
ferred from the aforementioned region to the C-terminal region,
through the binding interface, in a phenomenon called the cross-
saturation effect. The saturation transferred to the C-terminal
region is limited to the interface, due to its low proton density.
Therefore, the residues that are in close proximity to the mem-
brane surface can be identiﬁed by observations of the signal
intensity reductions of T360 and I399.
In the cross-saturation experiments using the phosphorylated
β2AR, the pT360 methyl resonances were remarkably affected by
irradiation, whereas the methyl resonances from T360 to I399
were not signiﬁcantly affected by irradiation in the experiments
using unphosphorylated β2AR (Fig. 4b, c). These results, together
with the above-described phosphorylation-induced broadening of
resonances from the amide groups in the TM-proximal region
(Fig. 2b), suggested that the TM-proximal region of β2AR adheres
to the membrane surface in rHDLs upon phosphorylation.
Conformation of the phosphorylated β2AR bound to
β-arrestin. To investigate the effect of arrestin binding on the
conformation of the TM region of the phosphorylated β2AR, we
observed the NMR resonances from the phosphorylated β2AR
mutant bound to β-arrestin 1. Surface plasmon resonance (SPR)
analyses revealed that a β2AR mutant binds to β-arrestin 1 in a
phosphorylayion-dependent manner (Supplementary Fig. 4), in
good agreement with the previously reported interaction between
GPCRs and arrestins26. In the crystal structure of rhodopsin
bound to visual arrestin, the residues corresponding to the
methionine residues in β2AR are >9 Å away from the arrestin
atoms, suggesting that the resonances from methionine residues
would be less affected by the direct interaction with β-arrestin 1,
and would be good probes to investigate the conformational
change of the TM region of β2AR upon β-arrestin 1 binding. In
the spectrum of the phosphorylated β2AR mutant bound to both
the full agonist and β-arrestin 1, the resonances from M2155.54
and M2796.41 exhibited different chemical shifts from those in the
spectrum of the unphosphorylated β2AR bound to the full agonist
(Fig. 5). Comparison of the spectra in unphosphorylated, phos-
phorylated, and β-arrestin 1-bound state revealed that the
M2155.54 resonance in the phosphorylated state was observed at a
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Fig. 3 Conformation of the TM region of phosphorylated β2AR. Overlay of
the 1H-13C HMQC spectra of [2H-9AA, αβγ-2H, methyl-13C-Met] β2AR in
rHDLs in the unphosphorylated state (black) and phosphorylated state
(red). Cross-sections of the resonances from M2155.54 and M2796.41 are
shown above the spectra
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chemical shift between those in the unphosphorylated state and
β-arrestin 1-bound state (Fig. 5).
Discussion
The C-terminal regions of GPCRs are predicted to be intrinsically
disordered, and the phosphorylated C-terminal regions and
cytoplasmic cavity of the TM regions were assumed to interact
with arrestins independently27, although this is not necessarily an
appropriate model for efﬁcient complex formation between
GPCRs and arrestins. In contrast, our cross-saturation
experiments using the segmentally labeled β2AR in rHDLs
revealed that the TM-proximal region of the C-terminal region
adheres to the membrane surface, which is composed of the TM
region or lipids in rHDLs (Fig. 4). The identiﬁed adhesion in this
study results in the spatial proximity between the phosphorylated
residues and the cytoplasmic cavity, which would be advanta-
geous for arrestin to bind simultaneously to both the phos-
phorylated residues and the cytoplasmic cavity (Fig. 6).
Upon phosphorylation, the amide and methyl resonances
derived from the TM-proximal region were broadened
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(Fig. 2b–d). The line broadening suggests that the phosphorylated
TM-proximal region interconverts between multiple states, which
are probably due to the negative-negative charge interaction
between the phosphorylated TM-proximal region and lipids.
The cross-saturation experiments revealed that either the TM
region of β2AR or lipids adhere to the phosphorylated TM-
proximal region (Fig. 4). Furthermore, we also observed the
perturbation of the resonances from M2155.54 and M2796.41,
which are located in the TM region, upon phosphorylation
(Fig. 3). It is unlikely that the interaction between the phos-
phorylated C-terminal region and lipids induces the observed
perturbation of the resonances from M2155.54 and M2796.41,
because the methyl groups of M2155.54 and M2796.41 are buried
in the TM helix bundle and >7 Å away from the lipid atoms. In
addition, the cytoplasmic face of the TM region of β2AR is
positively charged (Supplementary Fig. 5a), which would com-
plement the negatively charged phosphate groups incorporated
within the C-terminal region. In the original crystal structure of
rhodopsin from a native source28, an electron density was
observed in the intracellular core, and it is plausible that the
density reﬂects the interaction between the phosphorylated C-
terminal region and the TM region. Thus, it is most likely that the
phosphorylated TM-proximal region interacts with the cyto-
plasmic face of the TM region by an electrostatic interaction, and
the interaction alters the microenvironments around M2155.54
and M2796.41.
As in our previous NMR study of another GPCR29, the che-
mical shifts of the methionine methyl groups in the TM region
sensitively reﬂected the conformational change of the TM helices.
M2155.54 and M2796.41, which were perturbed upon phosphor-
ylation in the NMR spectra of β2AR, are located on the intra-
cellular halves of TMs 5 and 6, respectively, and the 1H chemical
shifts of M2155.54 and M2796.41 are affected by the ring current
effects from F2826.44 and Y2195.58, respectively, which are sen-
sitive to the spatial arrangement of the intracellular halves of TM5
and TM6, a possible arrestin binding site (Supplementary Fig. 6).
These chemical shift perturbations of the methionine residues
suggest that the intracellular halves of TM5 and TM6 become
spatially rearranged upon phosphorylation. Interestingly, the
M2155.54 resonance shifted toward that in the β-arrestin 1-bound
state upon phosphorylation (Fig. 5), suggesting that the
phosphorylation-induced conformational change of TM5 and
TM6, in addition to the adhesion of the phosphorylated C-
terminal region to the membrane surface, would be prerequisite
for β-arrestin recruitment (Fig. 6). Recent structural studies
indicated that G-proteins or conformation-selective nanobodies
modulate the conformation of the TM region from the intracel-
lular side30–34. The proposed phosphorylation-induced con-
formational change of the TM region could be considered as a
similar phenomenon. This is reasonable, since arrestin recognizes
both the phosphorylated C-terminal region and the TM region.
The resonances from M2155.54 of the phosphorylated β2AR
and the phosphorylated β2AR–β-arrestin 1 complex exhibited a
1H downﬁeld shift, in comparison with those of the unpho-
sphorylated β2AR. The observed 1H downﬁeld shift would cor-
respond to the inward movement of TM6, because F2826.44,
which deﬁnes the 1H chemical shift of M2155.54, moves away
from M2155.54, with the inward movement of TM6 (Supple-
mentary Fig. 6).
The crystal structures of GPCRs revealed that the degrees of
the outward movement of TM6 vary among GPCRs in active
states, from 3.5 to 14 Å (Supplementary Fig. 7). The proposed
inward movement of TM6 upon phosphorylation should be
included in the categories of these active state conformations.
Particularly, in the structure of rhodopsin bound to arrestin, the
degree of the outward movement of TM6 is smaller than that in
the structure of β2AR bound to G-protein, suggesting that arrestin
recognizes a GPCR that exhibits a relatively small outward
movement of TM6. The proposed inward movement of TM6
upon phosphorylation would thus be suitable for the
phosphorylation-dependent arrestin recruitment.
To validate the proposed inward movement of TM6 upon
phosphorylation, the capacity of the nanobody Nb6B9 was
examined by SPR methods. Nb6B9 selectively recognizes the
intracellular face of β2AR in the active state, with a large outward
movement of TM635. As a result, the responses observed for
Nb6B9 binding to the phosphorylated β2AR were lower than
those to the unphosphorylated β2AR (Supplementary Fig. 8),
which is consistent with the proposed phosphorylation-induced
inward movement of TM6.
Phosphorylation of the TM-proximal region on β2AR more
effectively promotes the arrestin binding than that of the TM-
distal region36. However, the mechanisms underlying the phos-
phorylation site-dependent arrestin recruitment are not under-
stood. The phosphorylation-induced adhesion of the C-terminal
region to the membrane surface and the conformational change
of the TM region, which occur on the TM-proximal region but
not on the TM-distal region, explain the phosphorylation site-
dependent arrestin recruitment.
Different GRK subtypes reportedly phosphorylate different
residues, and the patterns of the phosphorylated residues estab-
lish the phosphorylation barcode that dictates the conformation
of bound β-arrestins and subsequent functions such as inter-
nalization and MAP kinase activation37. The previous
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phosphorylation barcode theory solely focused on the position of
the phosphorylated residues on the primary sequence. On the
other hand, according to our NMR analyses, upon phosphor-
ylation, the TM-proximal region adhered to the TM region and
induced the conformational change of the TM helices, and that
the TM-distal region was ﬂexible even in the phosphorylated
state. These results suggested that phosphorylation of the C-
terminal region induced the conformational change dependent on
the position of the phosphorylated residues and thus the con-
formation of the C-terminal region induced by the phosphor-
ylation should be considered for understanding the regulation of
the arrestin function.
The basic regions around the cytoplasmic faces of TM5 and
TM6 are reportedly highly conserved among many GPCRs38, 39,
and the crystal structures of GPCRs other than β2AR also contain
positively charged clusters on the cytoplasmic face of the TM
region (Supplementary Fig. 5b–d), although their role in receptor
function is not well understood. It is plausible that the afore-
mentioned conformation of the phosphorylated β2AR, which is
induced by the interaction between the phosphorylated residues
and the positive charge clusters, is the general signature char-
acteristic of GPCRs. β-arrestins can recognize dozens of activated
and phosphorylated GPCRs, although the mechanism underlying
the wide target speciﬁcity is not well understood. The conserved
conformations of the phosphorylated GPCRs, characterized by
the adhesion of the phosphorylated residues to the TM region
and the inward movement of TM6 (Fig. 6), would be the struc-
tural motifs of GPCRs that enable β-arrestin to interact with
dozens of GPCRs.
Methods
Statistics and general methods. No statistical methods were used to pre-
determine sample size. The experiments were not randomized. The investigators
were not blinded to allocation during experiment and outcome assessment.
Reagents and buffers. All reagents were from Nacalai Tesque, Inc., unless
otherwise noted.
Generation of recombinant baculovirus expressing TM-IntN. The DNA frag-
ment encoding the hemagglutinin signal sequence, the FLAG-tag, previously
reported E122W/N187E/C265A mutant of β2AR (1–348, E122W, N187E, C265A),
and the N fragment of the DnaE intein from Nostoc punctiforme was cloned into
the pFastBac1 vector (Invitrogen). Primer sequences used to construct the plasmid
are listed in Supplementary Table 2.
Sf9 cells (Invitrogen) were routinely maintained at 27 °C in Grace’s
supplemented medium (GIBCO) containing 10% fetal bovine serum (Biowest),
0.1% Pluronic F-68 (GIBCO), 50 IUmL−1 penicillin, 50 μg mL−1 streptomycin, and
0.125 μg mL−1 amphotericin B. The recombinant baculovirus was generated and
ampliﬁed with the Bac-to-Bac system (Invitrogen), according to the manufacturer’s
instructions.
Expression and puriﬁcation of TM-IntN. The expresSF+ cells (SF+ cells, Protein
Science Corp.) were routinely maintained at 27 °C, in 100 mL Sf-900 II Serum free
medium (GIBCO) in a 250 mL Erlenmeyer ﬂask (Corning) on an orbital shaker
(130 rpm). For the expression of TM-IntN, the culture was expanded to 10 L in a
20 L Cellbag Bioreactor (GE Healthcare), using the Xuri cell expansion system W25
(GE Healthcare). When the cell density reached at about 2 × 106 cells mL−1, 400 mL
high-titer virus stocks, 1 μM alprenolol (SIGMA), and 14 μM E-64 (Peptide
Institute Inc.) were added, and the culture was continued. Cells were harvested 48 h
post-infection by centrifugation at 800 × g, and the resulting cell pellets were stored
at −80 °C.
All of the following procedures were performed either on ice or in the cold
room (4 °C). The cell pellet from 3 L of cell culture was suspended in 300 mL buffer
A (50 mM Tris–HCl, pH 8.0, 100 mM NaCl, 0.1 mM tris(2-carboxyethyl)
phosphine (TCEP), 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM 4-(2-
aminoetyl) benzenesulfonyl ﬂuoride hydrochloride (AEBSF), 20 μM leupeptin
hemisulfate (Peptide Institute Inc.), 28 μM E-64 (Peptide Institute Inc.), 0.3 μM
aprotinin (Wako Chemicals), 1 μM alprenolol (SIGMA)). The cells were disrupted
by nitrogen cavitation (Parr Bomb) under 600 psi for 30 min. The cell lysate was
centrifuged at 800 × g for 10 min, and the resulting supernatant was centrifuged at
142,000 × g for 40 min. The resulting pellet was washed twice in 80 mL buffer B
(50 mM HEPES-NaOH, pH 7.2, 1 M NaCl, 20 mM KCl, 10 mM MgCl2, 0.1 mM
TCEP, 1 mM AEBSF, 20 μM leupeptin hemisulfate, 28 μM E-64) and centrifuged at
142,000 × g for 40 min. The membrane pellet was resuspended in buffer C (20 mM
HEPES-NaOH, pH 7.2, 150 mM NaCl, 20% (w/v) glycerol, 0.1 mM TCEP)
supplemented with 1 μM alprenolol and was stored at −80 °C.
The membrane pellet from 3 L of cell culture was solubilized in 80 mL buffer C
supplemented with 1% n-dodecyl-β-D maltopyranoside (DDM, Dojindo) for 3 h,
and was then centrifuged at 142,000 × g for 60 min. The supernatant was
supplemented with 10 mM CaCl2, and batch incubated with 8 mL ANTI-FLAG M1
Afﬁnity Agarose Gel (SIGMA). The resin was washed with 100 mL buffer C,
supplemented with 1 μM alprenolol, 0.1% DDM, and 3 mM CaCl2. The protein was
eluted with 20 mL buffer C, supplemented with 1 μM alprenolol, 0.1% DDM, 5 mM
EDTA, and 0.2 mgmL−1 DYKDDDDK peptide (Wako Chemicals).
The eluate from the ANTI-FLAG M1 Afﬁnity Agarose Gel was further puriﬁed
by chromatography on a Superose 6 10/300 GL column (GE Healthcare),
equilibrated in buffer D (10 mM Tris–HCl, pH 7.5, 500 mM NaCl, 1 mM EDTA),
supplemented with 0.1% DDM and 0.1 mM TCEP.
Generation of the IntC-Cterm plasmid. The DNA fragment encoding a hex-
ahistidine-tag, the C fragment of the DnaE intein from Synechocystis species
PCC6803, and β2AR (349–413, A349C, C378A, C406A) was cloned into the pRSF-
1b vector (Novagen). The A349C/C378A/C406A mutations were introduced to
improve the efﬁciency of the PTS reaction. We conﬁrmed that the mutant retained
the ability to be phosphorylated by GRK2 in a ligand-dependent manner and
exhibited similar phosphorylation kinetics to those obtained in a previous study
using wild-type β2AR40 (Supplementary Fig. 1). For the observation of the methyl
resonances from T360γ2 to I399δ1, the T384A/T393A/S396A/S401A/S407A/
T408A/S411A mutant was utilized for speciﬁcally investigating the effect of the
phosphorylation of the TM-proximal region. Primer sequences used to construct
the plasmids are listed in Supplementary Table 2.
Expression and puriﬁcation of IntC-Cterm. The Escherichia coli ER2566 strain
(New England Biolabs), transformed with the IntC-Cterm plasmid was cultured in
10 mL Luria Bertani (LB) medium containing 50 mg L−1 kanamycin at 37 °C
overnight. The cells were used to inoculate in 1 L of D2O-based M9 medium,
supplemented with 2 g L−1 [2H7/13C6] glucose (Cambridge Isotope Laboratories,
CIL) and 1 g L−1 15NH4Cl (SI Science Co., Ltd.) as the sole carbon and nitrogen
source, respectively. When the culture attained to an optical density at a wave-
length of 600 nm (OD600) of 0.8, 1 mM isopropyl-β-D-thiogalactopyranoside
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adhesion of the phosphorylated C-terminal region to the TM-region and the spatial rearrangement of the TM helices would generate the structural motif
for β-arrestin binding
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(IPTG) was added, to induce protein expression. The culture was continued further
at 37 °C for 6 h. For the selective 13C1H3 labeling of the threonine γ2 and isoleucine
δ1 methyl groups, 50 mg L−1 of [α,β-2H2, γ2-13C1H3] threonine (NMR Bio), 100
mg L−1 of [2H2] glycine (NMR Bio), and 50 mg L−1 of [methyl-13C, 3,3-2H]
ketobutyric acid (CIL) were supplemented into the medium, 1 h before the addition
of IPTG. The cells were harvested by centrifugation at 5000 × g for 15 min, and
resulting cell pellets were stored at −80 °C.
The cells from a 1 L culture were suspended in 60 mL buffer E (50 mM
Tris–HCl, pH 8.0, 300 mM NaCl), supplemented with 2 mM dithiothreitol (DTT).
The cells were disrupted by sonication, and the cell lysate was centrifuged at
100,000 × g for 1 h. The supernatant was applied to a 1 mL HisTrap HP column
(GE Healthcare), equilibrated in buffer E. The protein was eluted by a linear
concentration gradient of imidazole, from 25 mM to 190mM. The eluate was
further puriﬁed by reverse-phase high performance liquid chromatography
(HPLC), using a YMC-Pack ODS AM-323 column (YMC), connected to
Prominence HPLC system (SHIMADZU). The eluate was lyophilized, dissolved in
H2O, pH adjusted to 7.5, and lyophilized again.
Ligation of TM-IntN and IntC-Cterm. Puriﬁed TM-IntN was concentrated, using a
centrifugal ﬁlter device (AmiconUltra-4, 30 kDa molecular weight cut off, Milli-
pore). Lyophilized IntC-Cterm was dissolved in a concentrated TM-IntN solution,
and incubated at 25 °C in the presence of 0.5 mM TCEP for 6 h. The ligation
reaction was monitored by SDS–PAGE.
Reconstitution of ligated β2AR into rHDLs. The Escherichia coli BL21 (DE3)
(Stratagene), transformed with the plasmid encoding His-tagged MSP115, was
cultured at 37 °C in Terriﬁc Bloth (TB) media containing 100 mg L−1 of ampicillin.
When the culture attained an OD600 of 2.0, 1 mM of IPTG was added to induce
protein expression. The culture was continued further at 37 °C for 3 h. The cells
were harvested by centrifugation at 5000 × g for 15 min, and the resulting cell
pellets were stored at −80 °C.
The cells were suspended in buffer F (50 mM Tris–HCl (pH7.5), 300 mM NaCl,
100 mM KCl) and disrupted by sonication. The cell lysate was centrifuged at
20,000 × g for 30 min, and the pellet was suspended in buffer F, supplemented in
1% Triton X-100. The suspension was centrifuged at 100,000 × g for 1 h, and the
supernatant was applied to HIS-Select resin (SIGMA). The resin was washed with
buffer F supplemented in 1 % Triton X-100, buffer F supplemented with 50 mM
Na-cholate, and buffer F supplemented with 20 mM imidazole. The His-tagged
MSP1 was eluted with buffer F supplemented with 200 mM imidazole.
Subsequently, TEV protease was added to the eluate, which was dialyzed against
buffer G (50 mM Tris-HCl, 10 mM NaCl, 0.5 mM EDTA) for 1 day. The sample
was then dialyzed against buffer C, and passed through the HIS-Select resin to
obtain the MSP1 without His-tag.
For the preparation of the biotinylated rHDL, C-terminally AVI-tagged MSP1
was co-expressed with a biotin ligase BirA in Escherichia coli AVB 101 (Avidity).
A mixture of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC, Avanti Polar
Lipids) and 1-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG, Avanti Polar
Lipids) in chloroform was prepared at a molar ratio of 3:2. The solvent was
evaporated under a nitrogen atmosphere and dried in vacuo to form a lipid ﬁlm.
The ﬁlm was solubilized in buffer H (20 mM HEPES-NaOH, pH 7.2, 150 mM
NaCl, 0.1 mM TCEP), supplemented with 100 mM sodium cholate, for a ﬁnal lipid
concentration of 50 mM.
All of the following procedures were performed either on ice or in the cold
room (4 °C) unless otherwise stated. The prepared MSP1 and the lipid solution
were added to the ligation reaction mixture at ﬁnal concentrations of 0.1 mM and
5mM, respectively. The mixture was incubated on ice for 3 h. Afterwards, 80% (w/
v) of Bio-Beads SM-2 (Bio-Rad) was added to the mixture, which was incubated in
the cold room overnight with gentle mixing. The supernatant was supplemented
with 10 mM CaCl2, and applied to a 1 mL ANTI-FLAG M1 Afﬁnity Agarose Gel
column, equilibrated in buffer H supplemented with 3 mM CaCl2. The resin was
washed with 5 mL buffer H supplemented with 3 mM CaCl2. The β2AR in rHDLs
were eluted with buffer H, supplemented with 5 mM EDTA and 0.2 mgmL−1
DYKDDDDK peptide.
For the preparation of the phosphorylated β2AR in rHDL, the elution buffer was
exchanged to buffer I (20 mM Tris–HCl, pH 7.5, 10 mM MgCl2, 0.1 mM TCEP),
using a PD-10 desalting column (GE Healthcare). Puriﬁed GRK2, ATP, and
formoterol were added at ﬁnal concentrations of 1.5 μM, 1 mM, and 100 μM,
respectively. The reaction mixture was incubated at 30 °C for 1.5 h, and was
analyzed by SDS–PAGE with Pro-Q® Diamond and SYPRO®-Ruby (Molecular
Probes) staining. Gel images were obtained with a Typhoon FLA 9000 imager (GE
Healthcare).
The eluate from the ANTI FLAG M1 Afﬁnity Agarose Gel or the
phosphorylated mixture was further puriﬁed on a Superdex 200 10/300 GL increase
column (GE Healthcare) equilibrated in buffer H. The fractions corresponding to a
Stokes diameter of ~ 11 nm were collected, supplemented with 20 μM formoterol,
and concentrated using a centrifugal ﬁlter device (Amicon Ultra-4 10 kDa of
molecular weight cut-off, Millipore), while exchanging the buffer to buffer J (20
mM PIPES-NaOH, pH 6.8, 2 mM EDTA, 0.1 mM TCEP, H2O/D2O = 90/10).
Preparation of the β2AR 4Met mutant embedded in rHDLs. The DNA fragment
encoding the hemagglutinin signal sequence, the FLAG-tag, β2AR (2–413) with the
4Met mutation, and a decahistidine-tag, was cloned into the pFastBac1 vector
(Invitrogen). The generation of the recombinant baculovirus was performed as
described above for TM-IntN. For the expression of [2H-9AA, αβγ-2H, methyl-13C-
Met] β2AR, SF+ cells were suspended in ESF921 ΔAA media (Expression Systems),
supplemented with 3 g L−1 aspartic acid sodium salt, 2 g L−1 glutamic acid sodium
salt, 1.5 g L−1 glutamine, 1.5 g L−1 asparagine, 1.0 g L−1 lysine hydrochloride, 1.0 g L
−1 arginine hydrochloride, 0.5 g L−1 glycine, 0.5 g L−1 serine, 0.5 g L−1 proline, 0.5 g
L−1 hydroxyproline, 0.3 g L−1 histidine, 0.1 g L−1 [ring-2H]-tryptophan (CIL), 0.05
g L−1 [αβγ-2H, methyl-13C]-methionine (CIL), 0.27 g L−1 [β- 2H]-DL-cysteine
(CIL), and 0.1 g L−1 [2H]-DL-tyrosine, at about 2 × 106 cells mL−1. The cells were
cultured with high-titer virus stock. At 20 h post infection, 1.5 g L−1 [2H]-algal
amino-acid mixture (CIL), 0.1 g L−1 [αβγ-2H, methyl-13C]-methionine, 0.05 g L−1
[2H]-phenylalanine (CIL), 0.05 g L−1 [2H]-valine (CIL), 1 g L−1 [2H]-alanine, and
0.01 g L−1 β-chloro-L-alanine hydrochloride, were added to the culture. Cells were
collected at 48 h post infection by centrifugation at 800 × g, and resulting pellet was
stored at −80 °C.
The preparation of membrane and solubilization by DDM was performed as
described for the puriﬁcation of TM-IntN. The supernatant was batch incubated
with TALON resin for overnight. The resin was washed with buffer C
supplemented with 0.1% DDM and 20 mM imidazole. The protein was eluted with
buffer C supplemented with 0.1% DDM and 200 mM imidazole. The eluate was
batch incubated for 4 h with Afﬁ-gel 10 (Bio-Rad), on which 5 mgmL−1 alprenolol-
cysteamine was immobilized. The resin was washed with buffer C, supplemented
with 0.1% DDM. β2AR was eluted with buffer C supplemented with 0.1 % DDM
and 1 mM formoterol.
For the analysis of β2AR bound to β-arrestin 1, the amino acid sequence of the
β2AR C-terminal region (residues 342–413) was substituted with that of the human
arginine vasopressin V2 receptor C-terminal region (residues 343–371), to achieve
the high-afﬁnity interaction with β-arrestin 141. For the puriﬁcation of this mutant,
the His-tag puriﬁcation steps using TALON resin (Clontech) were replaced by the
FLAG-tag puriﬁcation steps, using ANTI-FLAG M1 Afﬁnity Agarose Gel (SIGMA)
because this mutant lacked the C-terminal His-tag. The FLAG-tag puriﬁcation was
performed as described for the puriﬁcation of TM-IntN.
Generation of the β-arrestin 1 plasmid. The DNA fragment encoding the hex-
ahistidine-tag, the TEV-protease cleavage site (ENLYFQG), and the human β-
arrestin 1 cysteine-less mutant42 was cloned into the pTrcHisB vector (Thermo
Fisher Scientiﬁc). Primer sequences used to construct the plasmid are listed in
Supplementary Table 2.
Expression and puriﬁcation of β-arrestin 1. The Escherichia coli BL21 (DE3)
codon plus RP strain (Stratagene), transformed with the β-arrestin 1 plasmid was
cultured in 10 mL Luria Bertani (LB) medium containing 100 mg L−1 ampicillin at
37 °C overnight. The overnight culture was used to inoculated in 1 L of D2O-based
M9 medium, supplemented with 2 g L−1 [2H7] glucose and 1 g L−1 15NH4Cl as the
sole carbon and nitrogen sources, respectively. When the culture attained an OD600
of 0.8, 0.3 mM isopropyl-β-D-thiogalactopyranoside (IPTG) was added to induce
protein expression. The culture was continued further at 30 °C for 20 h. For the
selective 13C1H3 labeling of the isoleucine δ1 methyl group, 50 mg L−1 of [methyl-
13C, 3,3-2H] ketobutyric acid were supplemented into the medium 1 h before the
IPTG addition. The cells were harvested by centrifugation at 5000 × g for 15 min,
and the resulting cell pellets were stored at −80 °C.
The cells from a 1 L culture were suspended in 60 mL buffer K (20 mM Tris-
HCl, pH 8.0, 200 mM NaCl) supplemented with Protease Inhibitor Cocktail. The
Cells were disrupted by sonication, and the cell lysate was centrifuged at 100,000 ×
g for 1 h. The supernatant was applied to a 1 mL HisTrap HP column (GE
Healthcare), equilibrated in buffer K. The protein was eluted by a linear
concentration gradient of imidazole, from 25 mM to 175 mM. Subsequently, 1 mg
of TEV protease was added to the eluate, which was dialyzed against buffer L (20
mM Tris–HCl, pH 8.0, 2 mM EDTA) supplemented with 150 mM NaCl, for 16–18
h. The samples were applied to a 1 mL HiTrap Heparin HP (GE Healthcare),
equilibrated with buffer L. The protein was eluted by a linear concentration
gradient of NaCl, from 200 mM to 700 mM. The eluate was concentrated using a
centrifugal ﬁlter device (Amicon Ultra-4 30 kDa molecular weight cut-off,
Millipore), and further puriﬁed on a Superdex 75 10/300 GL column (GE
Healthcare), equilibrated in buffer L supplemented with 300 mM NaCl. The eluate
was concentrated using a centrifugal ﬁlter device (Amicon Ultra-4 30 kDa
molecular weight cut-off, Millipore), while exchanging the buffer to buffer F
prepared in H2O/D2O = 1/99.
Preparation of Nb6B9. The DNA fragment encoding the C-terminally H8-tagged
Nb6B935 was cloned into the pET26b vector (Novagen) by using restriction
enzymes NdeI and EcoRI (TAKARA BIO). The resulting sequence to be translated
contains additional two residues (Met-Asp) at the N terminus and a lysine residue
just upstream of the C-terminal H8-tag.
The Eschericha coli SHufﬂe T7 Express43 (NEW ENGLAND Biolabs)
transformed with the Nb6B9 plasmid was cultured at 30 °C in LB media containing
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30 mg L−1 of kanamycin. When the culture attained an OD600 of 0.8, 0.4 mM of
IPTG was added to induce protein expression. The culture was continued further at
16 °C for 16 h. The cells were collected by centrifugation at 5000 × g for 15 min, and
the resulting cell pellets were stored at −80 °C.
The cells were suspended in buffer M (50 mM Tris–HCl (pH7.5), 150 mM
NaCl, 1 mM phenylmethylsulfonyl ﬂuoride) and disrupted by sonication. The cell
lysate was centrifuged at 27,000 × g for 30 min, and the supernatant was puriﬁed by
the His-tag afﬁnity chromatography using TALON resin (Clontech). The fractions
containing Nb6B9 were pooled and further puriﬁed by size exclusion
chromatography using Superdex 75 10/300 GL column (GE lifesciences) with
buffer N (20 mM Hepes-NaOH (pH 6.5), 300 mM NaCl).
Surface plasmon resonance experiments. The β-arrestin 1 and Nb6B9 binding
activities of unphosphorylated or phosphorylated β2AR mutants were analyzed
using Biacore T100 or Biacore T200 instrument (GE Healthcare). The β2AR
mutants embedded in biotinylated rHDLs were captured on the ﬂow cells of the
Series S Sensor Chip SA (GE Healthcare) via the interaction between biotin and
streptavidin. The binding assays were carried out in buffer H, supplemented with 1
μM formoterol, at a ﬂow rate of 30 μLmin−1. The obtained sensorgrams were
processed using Biacore T-200 Evaluation software (GE Healthcare).
NMR experiments. All spectra were recorded with a Bruker AVANCE III 800 or
Bruker AVANCE III 950 spectrometer equipped with a cryogenic probe, processed
by Topspin 3.1 (Bruker), and analyzed by Sparky44. The 1H chemical shifts were
referenced to the methyl protons of 3-(trimethylsilyl)-1-propanesulfonic acid
sodium salt, and the 13C and 15N chemical shifts were referenced indirectly.
1H-15N HSQC spectra with water ﬂip-back and WATERGATE were recorded
for 10–20 μM {Cterm-[2H,13C,15N]} β2AR in rHDLs in buffer J, supplemented with
20 μM formoterol. The spectral widths were set to 16 and 22 ppm for the 1H and
15N dimension, respectively, and the inter-scan delays were set to 1 s. In total,
512 × 128 complex points were recorded, and 256 scans/FID gave rise to an
acquisition time of 20 h for each spectrum.
TROSY-HNCA and TROSY-HN(CO)CA were recorded for ~ 20 μM {Cterm-
[2H,13C,15N]} β2AR in rHDLs in buffer J, supplemented with 20 μM formoterol.
The spectral widths were set to 16, 22, and 24 ppm for the 1H, 13C, and 15N
dimensions, respectively, and the inter-scan delays were set to 1 s. In total, 1,024 ×
30 × 32 complex points were recorded, and 24 scans/FID gave rise to an acquisition
time of 36 h for each spectrum.
1H-13C HMQC spectra with echo/anti-echo gradient coherence selection were
recorded for ~ 10 μM {Cterm- [2H, Thrγ2/Ileδ1-13C1H3]} β2AR in rHDLs in buffer
J, prepared in H2O/D2O = 1/99 and supplemented with 20 μM formoterol. The
spectral widths were set to 16 and 8 ppm for the 1H and 13C dimension,
respectively, and the inter-scan delays were set to 1 s. In total, 512 × 128 complex
points were recorded, and 256 scans/FID gave rise to an acquisition time of 20 h for
each spectrum.
Methyl-utilizing intramolecular CS spectra were recorded for ~ 10 μM {Cterm-
[2H, Thrγ2/Ileδ1-13C1H3]} β2AR in rHDLs in buffer J, prepared in H2O/D2O = 1/
99 and supplemented with 20 μM formoterol. The irradiation frequency was set at
5.0 ppm, and the maximum radiofrequency amplitude was 0.21 kHz for WURST-
20 (the adiabatic factor Q0 = 1). The irradiation times and the additional relaxation
time were set to 0.5 and 1.5 s, respectively.
1H-13C HMQC spectra were recorded for ~ 20 μM [2H-9AA, αβγ-2H-methyl-
13C-Met] β2AR 4Met mutant embedded in rHDLs. The spectral widths were set to
16 and 32 ppm for the 1H and 13C dimension, respectively, and the inter-scan
delays were set to 1 s. In total, 512 × 128 complex points were recorded, and
256 scans/FID gave rise to an acquisition time of 20 h for each spectrum.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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